Zydus Alidac

Zydus Lifesciences, formerly known as Cadila Healthcare, is a leading global pharmaceutical company headquartered in India. The company is a fully integrated healthcare provider with strengths across the entire pharmaceutical value chain, including research and development, manufacturing, and marketing of finished dosage forms, active pharmaceutical ingredients, and consumer wellness products. Zydus is notably recognized for developing Saroglitazar, the world's first drug for Nonalcoholic Steatohepatitis (NASH), and ZyCoV-D, the world's first plasmid DNA vaccine for COVID-19. With a robust pipeline of biosimilars and novel chemical entities, the company serves diverse therapeutic areas such as oncology, cardiology, and gastroenterology.